To determine the role of microglia in r(T)MS-induced synaptic plasticity, organotypic tissue cultures were treated with the CSF-1R antagonist PLX3397, which readily depletes microglia (Elmore et al., 2014; Coleman et al., 2020). Here, CSF1R is linked to myeloid sarcoma.